D. E. Shaw & Co., Inc. Cytokinetics Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 19,084 shares of CYTK stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,084

Previous 72,700 73.75%

Holding current value

$1.13 Million

Previous $2.92 Million 78.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$29.84 - $42.92 $172,534 - $248,163	5,782 Added 43.47%	19,084 $630,000
Q1 2025 May 15, 2025	BUY	$40.19 - $51.12 $534,607 - $679,998	13,302 New	13,302 $534,000
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $603,883 - $709,286	11,790 New	11,790 $622,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $2.33 Million - $3.95 Million	36,554 New	36,554 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.62 Million - $2.29 Million	41,935 New	41,935 $2.03 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $3.16 Million - $4.89 Million	-106,281 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $3.65 Million - $4.93 Million	106,281 New	106,281 $4.84 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $1.83 Million - $2.49 Million	-92,247 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $767,479 - $1.06 Million	41,329 Added 81.17%	92,247 $2.15 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $777,008 - $1.46 Million	50,918 New	50,918 $1.06 Million
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $1.01 Million - $1.42 Million	-49,028 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $176,203 - $389,385	15,803 Added 47.56%	49,028 $1.16 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $2.09 Million - $3.9 Million	-239,325 Reduced 87.81%	33,225 $392,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $1.85 Million - $2.75 Million	232,113 Added 574.01%	272,550 $2.89 Million
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $417,186 - $549,437	-38,557 Reduced 48.81%	40,437 $460,000
Q2 2019 Aug 14, 2019	SELL	$7.95 - $11.25 $1.02 Million - $1.44 Million	-128,245 Reduced 61.88%	78,994 $889,000
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $119,928 - $205,389	20,156 Added 10.77%	207,239 $1.68 Million
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $362,543 - $569,885	61,344 Added 48.79%	187,083 $1.18 Million
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $44,723 - $68,831	6,988 Added 5.88%	125,739 $1.24 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $106,211 - $152,390	15,393 Added 14.89%	118,751 $986,000
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $80,150 - $111,876	11,132 Added 12.07%	103,358 $745,000
Q4 2017 Feb 14, 2018	SELL	$7.25 - $15.65 $387,440 - $836,336	-53,440 Reduced 36.69%	92,226 $752,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $1.75 Million - $2.18 Million	145,666	145,666 $2.11 Million

Others Institutions Holding CYTK

# of Institutions

383

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.59B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account